Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VINEET LABORATORIES Plunges 10%; BSE HEALTHCARE Index Down 0.3%
Wed, 14 Aug 9:54

VINEET LABORATORIES Plunges 10%; BSE HEALTHCARE Index Down 0.3%Image source: KanawatTH/www.istockphoto.com

VINEET LABORATORIES share price has plunged 10% and is presently trading at Rs 58.2.

Meanwhile, the BSE HEALTHCARE index is at 40,920.8 (down 0.3%).

Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 2.6%) and Biocon (down 1.8%).

AJANTA PHARMA (up 3.1%) and Glenmark Pharma (up 1.3%) are among the top gainers today.

Over the last one year, VINEET LABORATORIES has moved up from Rs 51.7 to Rs 58.2, registering a gain of Rs 6.4 (up 12.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,920.8, registering a gain of 47.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.6%), GSK Pharma (up 100.5%) and SUVEN PHARMACEUTICALS (up 95.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,103.9 (up 0.2%).

The top gainers among the BSE Sensex today are TCS (up 1.5%) and M&M (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.

In the meantime, NSE Nifty is at 24,157.1 (up 0.1%). TCS and M&M are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,103.9, registering a gain of 13,702.0 points (up 21.0%).

VINEET LABORATORIES Financial Update...

VINEET LABORATORIES net profit fell 45.8% YoY to Rs 19 million for the quarter ended March 2024, compared to a profit of Rs 35 million a year ago. Net sales declined 35.2% to Rs 370 million during the period as against Rs 572 million in January-March 2023.

For the year ended March 2023, VINEET LABORATORIES reported 81.1% decrease in net profit to Rs 13 million compared to net profit of Rs 66 million during FY22. Revenue of the company grew 11.0% to Rs 2,123 million during FY23.

The current Price to earnings ratio of VINEET LABORATORIES, based on rolling 12 month earnings, stands at 52.3.


Equitymaster requests your view! Post a comment on "VINEET LABORATORIES Plunges 10%; BSE HEALTHCARE Index Down 0.3%". Click here!